| 1 (35) | Pfizer * | MUL |  |
| 2 (49) | Novartis, Switzerland | CHE | |
| 3 (53) | Johnson & Johnson * | MUL | |
| 4 (57) | Pfizer Inc, United States | USA | |
| 5 (58) | Sanofi * | MUL | |
| 6 (60) | F Hoffmann-La Roche * | MUL | |
| 7 (62) | Novartis * | MUL | |
| 8 (66) | Sanofi, United States | USA | |
| 9 (73) | Hoffmann-La Roche Ltd, United States | USA | |
| 10 (76) | AstraZeneca * | MUL | |
| 11 (77) | Janssen Biotech Inc | USA | |
| 12 (80) | Janssen | MUL | |
| 13 (84) | GlaxoSmithKline * | MUL | |
| 14 (85) | Novartis Pharmaceuticals, United States | USA | |
| 15 (89) | Genentech Inc | USA | |
| 16 (90) | GlaxoSmithKline, United Kingdom | GBR | |
| 17 (111) | Eli Lilly * | MUL | |
| 18 (138) | Eli Lilly and Company, United States | USA | |
| 19 (150) | Merck * | MUL | |
| 20 (167) | Bristol-Myers Squibb Company * | MUL | |
| 21 (169) | Bristol-Myers Squibb Company, United States | USA | |
| 22 (174) | UCB Pharma SA * | MUL | |
|
